# A Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in Patients With Diabetes

> **NCT01102452** · NA · COMPLETED · sponsor: **Pharma Power Biotec Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Commercially Available Wet Noodle
- **DIETARY_SUPPLEMENT:** PPB-R-203-02 Noodle

## Key facts

- **NCT ID:** NCT01102452
- **Lead sponsor:** Pharma Power Biotec Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102452, "A Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in Patients With Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01102452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*